4 new cases of COVID-19 out of 670 tested

291

Four (4) new cases of COVID-19 were identified out of 670 tests performed by DPHSS on Sunday, March 28, and tests from additional labs from Friday, March 26 to Sunday, March 28. Two (2) cases reported recent travel history and were identified in quarantine. Two (2) cases were identified through contact tracing.

To date, there have been a total of 7,804 officially reported cases of COVID-19 with 134 deaths, 33 cases in active isolation, and 7,637 not in active isolation.

TODAY’S CAR SCORE

0.2

The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.

The following tables provide COVID-19 test results additional labs from Friday, March 26 to Sunday, March 28:

COVID-19 CASE COUNT

TOTAL

NEW CASES REPORTED TODAY

PAST 7 DAYS

COVID-19 CASES:

7,804

4

20

CONFIRMED CASES:

7,594

4

20

PROBABLE CASES:

210

0

0

 

COVID-19 TESTING

ON GUAM

TOTAL

NEW TESTS

REPORTED TODAY

7-DAY

% POSITIVE

DIAGNOSTIC TESTS

140,024

670

0.9%

MOLECULAR TESTS

129,824

557

0.9%

ANTIGEN TEST

10,200

113

0%

SEROLOGY TESTS

365

0

0%

 

CASE BREAKDOWN

STATUS

TOTAL

CURRENT ISOLATION LOCATION

TOTAL

COVID-19 Death

134

Hospital

2

Active Isolation

33

Home

15

Not In Isolation

7,637

Isolation Facility

8

Civilian

7,402

Military

8

Military Service Member

402

 

COVID HOSPITAL CENSUS

Guam Memorial Hospital

Guam Regional Medical City

U.S. Naval Hospital

TOTAL

COVID ADMISSION

1

1

0

2

IN ICU

0

0

0

0

ON VENTILATOR

0

0

0

0

 

Preliminary COVID-19 vaccinations administered from December 17 to March 28:

Vaccine Maker

1st Doses Administered

2nd Doses Administered

Fully Immunized

Pfizer-BioNTech

31,339

16,323*

16,323

Moderna

17,899**

14,806***

14,806

Johnson & Johnson Janssen

42****

TOTALS:

49,238

31,129

31,171

*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.

**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.

***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.

****Johnson &Johnson/Janssen COVID-19 vaccinations began on March 15 and were developed as a one-dose series.

 

Total Doses Administered

Total Doses Allotted

% Administered

Doses Remaining

80,409^

87,860^^

91.52%

7,451

^As of March 28 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states, “After dilution, one vial contains six doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains five doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received an allocation of 1,300 Johnson & Johnson Janssen vaccines on March 8, 2021.

(JIC Release No. 617)

##